Drugs / Trivalent influenza vaccine (contains B/Victoria strain)
Trivalent influenza vaccine (contains B/Victoria strain)
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03853993 Comparator | Jan → Aug 2018 | influenza | Sinovac Biotech Co., Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Trivalent influenza vaccine (contains B/Victoria strain) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03853993 ↗ |
| Modality | Vaccine | “inactivated trivalent influenza vaccine (IIV3) which contains either B/Victoria strain (BV) or B/Yamagata strain (BY)” PMID 32732142 ↗ Jul 2020 |